Academic Journals Database
Disseminating quality controlled scientific knowledge

Pharmacogenomics and Personalized Medicine

ISSN: 1178--7066
Publisher: Dove Press


ADD TO MY LIST
 
Patient selection and targeted treatment in the management of platinum-resistant ovarian cancer

Author(s): Leamon PC | Lovejoy CD | Nguyen B
Volume: 2013
Issue: default
Year: 2013
Delivering pharmacogenetic testing in a primary care setting

Author(s): Mills R | Voora D | Peyser B | Haga SB
Volume: 2013
Issue: default
Year: 2013
Lack of correlation between in silico projection of function and quantitative real-time PCR-determined gene expression levels in colon tissue

Author(s): Penney RB | Lundgreen A | Yao-Borengasser A | Koroth-Edavana V | Williams S | Wolff R | Slattery ML | Kadlubar S
Volume: 2013
Issue: default
Year: 2013
CYP2C19 polymorphisms in the Thai population and the clinical response to clopidogrel in patients with atherothrombotic-risk factors

Author(s): Sukasem C | Tunthong R | Chamnanphon M | Santon S | Jantararoungtong T | Koomdee N | Prommas S | Puangpetch A | Vathesatogkit P
Volume: 2013
Issue: default
Year: 2013
Role of biomarkers in understanding and treating children with asthma: towards personalized care

Author(s): Lang JE | Blake KV
Volume: 2013
Issue: default
Year: 2013
ABCB1 haplotypes do not influence transport or efficacy of tyrosine kinase inhibitors in vitro

Author(s): Skoglund K | Boiso Moreno S | Baytar M | Jönsson JI | Gréen H
Volume: 2013
Issue: default
Year: 2013
Bosutinib: a SRC–ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia

Author(s): El Rassi F | Khoury HJ
Volume: 2013
Issue: default
Year: 2013
Molecular targeted therapies in metastatic melanoma

Author(s): Chakraborty R | Wiel | CN | Comfere NI
Volume: 2013
Issue: default
Year: 2013
Association of CYP2D6 and CYP2C19 polymorphisms and disease-free survival of Thai post-menopausal breast cancer patients who received adjuvant tamoxifen

Author(s): Chamnanphon M | Pechatanan K | Sirachainan E | Trachu N | Chantratita W | Pasomsub E | Noonpakdee W | Sensorn I | Sukasem C
Volume: 2013
Issue: default
Year: 2013
Non-small-cell lung cancer: molecular targeted therapy and personalized medicine – drug resistance, mechanisms, and strategies

Author(s): Sechler M | Cizmic AD | Avasarala S | Van Scoyk M | Brzezinski C | Kelley N | Bikkavilli RK | Winn RA
Volume: 2013
Issue: default
Year: 2013
Copy number variation in sulfotransferase isoform 1A1 (SULT1A1) is significantly associated with enzymatic activity in Japanese subjects

Author(s): Yu X | Kubota T | Dhakal I | Hasegawa S | Williams S | Ozawa S | Kadlubar S
Volume: 2013
Issue: default
Year: 2013
GSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer

Author(s): Zhang X | Huang M | Wu X | Kadlubar S | Lin J | Yu X | Fan C | Ning B | Kadlubar FF
Volume: 2013
Issue: default
Year: 2013
 Pharmacogenomic considerations in opioid analgesia. [Corrigendum]

Author(s): Vuilleumier PH | Stamer UM | Landau R
Volume: 2013
Issue: default
Year: 2013
Importance of pharmacogenetics in the treatment of children with attention deficit hyperactive disorder: a case report

Author(s): Tan-kam T | Suthisisang C | Pavasuthipaisit C | Limsila P | Puangpetch A | Sukasem C
Volume: 2013
Issue: default
Year: 2013
CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients

Author(s): Sirachainan E | Jaruhathai S | Trachu N | Panvichian R | Sirisinha T | Ativitavas T | Ratanatharathorn V | Chamnanphon M | Sukasem C
Volume: 2012
Issue: default
Year: 2012
Drug targets and predictive biomarkers in the management of metastatic melanoma

Author(s): Thumar J | Giesen E | Kluger HM
Volume: 2012
Issue: default
Year: 2012
Boceprevir and personalized medicine in hepatitis C virus infection

Author(s): Habersetzer F | Leboeuf C | Doffoël M | Baumert TF
Volume: 2012
Issue: default
Year: 2012
Personalized medicine and treatment approaches in non-small-cell lung carcinoma

Author(s): Vadakara J | Borghaei H
Volume: 2012
Issue: default
Year: 2012
Role of pharmacogenomics in the treatment of tuberculosis: a review

Author(s): Ramachandran G | Swaminathan S
Volume: 2012
Issue: default
Year: 2012
Mu opioid receptor (OPRM1) as a predictor of treatment outcome in opiate-dependent individuals of Arab descent

Author(s): AL-Eitan LN | Jaradat SA | Su SY | Tay GK | Hulse GK
Volume: 2012
Issue: default
Year: 2012
ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics

Author(s): Barratt DT | Coller JK | Hallinan R | Byrne A | White JM | Foster DJR | Somogyi AA
Volume: 2012
Issue: default
Year: 2012
A genetic approach to the prediction of drug side effects: bleomycin induces concordant phenotypes in mice of the collaborative cross

Author(s): Gelinas R | Chesler EJ | Vasconcelos D | Miller DR | Yuan Y | Wang K | Galas D
Volume: 2011
Issue: default
Year: 2011
ERCC1 and XRCC1 as biomarkers for lung and head and neck cancer

Author(s): Vaezi A | Feldman CH | Niedernhofer LJ
Volume: 2011
Issue: default
Year: 2011
Role of 5-HT2C receptor gene variants in antipsychotic-induced weight gain

Author(s): Wallace TJM | Zai CC | Brandl EJ | Müller DJ
Volume: 2011
Issue: default
Year: 2011
Clinical application of high throughput molecular screening techniques for pharmacogenomics

Author(s): Wiita AP | Schrijver I
Volume: 2011
Issue: default
Year: 2011
Clinical implementation of RNA signatures for pharmacogenomic decision-making

Author(s): Tang W | Hu Z | Muallem H | Gulley ML
Volume: 2011
Issue: default
Year: 2011
Role of cytochrome P450 genotype in the steps toward personalized drug therapy

Author(s): Cavallari LH | Jeong H | Bress A
Volume: 2011
Issue: default
Year: 2011
Sulfation of fulvestrant by human liver cytosols and recombinant SULT1A1 and SULT1E1

Author(s): Edavana VK | Yu X | Dhakal IB | Williams S | Ning B | Cook IT | Caldwell D | Falany CN | Kadlubar S
Volume: 2011
Issue: default
Year: 2011
Individualization of antiretroviral therapy

Author(s): Pavlos R | Phillips EJ
Volume: 2012
Issue: default
Year: 2011
Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy

Author(s): Kenna GA | Roder-Hanna N | Leggio L | Zywiak WH | Clifford J | Edwards S | Kenna JA | Shoaff J | Swift RM
Volume: 2012
Issue: default
Year: 2012
The role of genetics in pre-eclampsia and potential pharmacogenomic interventions

Author(s): Williams PJ | Morgan L
Volume: 2012
Issue: default
Year: 2012
Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine

Author(s): Peter Avery | Shaymaa S Mousa | Shaker A Mousa
Volume: 2009
Issue: default
Year: 2009
Pharmacogenomics in osteoporosis: Steps toward personalized medicine

Author(s): Robert Greene | Shaymaa S Mousa | Mohamed Ardawi | et al
Volume: 2009
Issue: default
Year: 2009
The implications of pharmacogenomics in the treatment of HIV-1-infected patients of African descent

Author(s): Hector Clarke | Shaker A Mousa
Volume: 2009
Issue: default
Year: 2009
Pharmacogenomics in cardiovascular disorders: Steps in approaching personalized medicine in cardiovascular medicine

Author(s): Christopher Barone | Shaymaa S Mousa | Shaker A Mousa
Volume: 2009
Issue: default
Year: 2009
Influence of socioeconomic lifestyle factors and genetic polymorphism on type 2 diabetes occurrences among Tunisian Arab and Berber groups of Djerba Island

Author(s): Thouraya Baroudi Ouederni | Ahmed Fadiel | Nejla Stambouli | et al
Volume: 2009
Issue: default
Year: 2009
Genomics and proteomics: Applications in autoimmune diseases

Author(s): Wolfgang Hueber | William H Robinson
Volume: 2009
Issue: default
Year: 2009
Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid  dependence: A meta-analysis

Author(s): Janet K Coller | Julia Beardsley | James Bignold | Yibai Li | Florence Merg | et al
Volume: 2009
Issue: default
Year: 2009
Integrating epigenomics into pharmacogenomic studies

Author(s): Wei Zhang | R Stephanie Huang | M Eileen Dolan
Volume: 2008
Issue: default
Year: 2008
Association study of a brain-derived neurotrophic factor polymorphism and short-term antidepressant response in major depressive disorders

Author(s): Eugene Lin | Po See Chen | Lung-Cheng Huang | Sen-Yen Hsu
Volume: 2008
Issue: default
Year: 2008
The future role of personalized medicine in the treatment of glioblastoma multiforme

Author(s): Jing Li | Chunhui Di | Austin K Mattox | et al
Volume: 2010
Issue: default
Year: 2010
Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management

Author(s): Sarah Rofaiel | Esther N Muo | Shaker A Mousa
Volume: 2010
Issue: default
Year: 2010
Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy

Author(s): Bluth MH | Li J
Volume: 2011
Issue: default
Year: 2011
Tailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed

Author(s): Steven F Powell | Arkadiusz Z Dudek
Volume: 2009
Issue: default
Year: 2009
Determinants to optimize response to clopidogrel in acute coronary syndrome

Author(s): Betti Giusti | Anna Maria Gori | Rossella Marcucci | et al
Volume: 2010
Issue: default
Year: 2010
DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics

Author(s): Darko Turic | James Swanson | Edmund Sonuga-Barke
Volume: 2010
Issue: default
Year: 2010
Ofatumumab: a novel monoclonal anti-CD20 antibody

Author(s): Thomas S Lin
Volume: 2010
Issue: default
Year: 2010
Antiplatelet agents and proton pump inhibitors – personalizing treatment

Author(s): Eugene Lin | Rajiv Padmanabhan | Majaz Moonis
Volume: 2010
Issue: default
Year: 2010
Impact of genetic polymorphisms on clinical response to antithrombotics

Author(s): Kena J Lanham | Julie H Oestreich | Steven P Dunn | et al
Volume: 2010
Issue: default
Year: 2010
Update and developments in the treatment of glioblastoma multiforme – focus on bevacizumab

Author(s): Naveed Wagle | Leia Nghiemphu | Albert Lai | et al
Volume: 2010
Issue: default
Year: 2010
Optimizing response to gefitinib in the treatment of non-small-cell lung cancer

Author(s): Pietro Carotenuto | Cristin Roma | Anna Maria Rachiglio | et al
Volume: 2011
Issue: default
Year: 2011
Pharmacogenetics of rheumatoid arthritis: Potential targets from susceptibility genes and present therapies

Author(s): Darren D O’Rielly | Proton Rahman
Volume: 2010
Issue: default
Year: 2010
Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin

Author(s): Roberto J Carvalho-Filho | Olav Dalgard
Volume: 2010
Issue: default
Year: 2010
Why do you need a reservation system?      Affiliate Program